Home ยป MKSAP 18 Audio Companion - 06 Rheumatology
MKSAP 18 Audio Companion - 06 Rheumatology
- 06 Rheumatology.pdf
- 01-01 Introduction to Rheumatology Section.m4a
- 01-02 Approach to the Patient with Rheumatologic Disease.m4a
- 01-03 The Musculoskeletal Examination.m4a
- 01-04 Session MCQ Item 20 An 85-year-old Woman is Evaluated for Left Knee Pain.m4a
- 01-05 Arthritis.m4a
- 01-06 Extra-Articular Manifestations of Rheumatologic Disease.m4a
- 01-07 Session MCQ Item 28 A 43-year-old Woman has Left Knee Pain and Swelling.m4a
- 01-08 Dermatologic Manifestations of Rheumatologic Disease.m4a
- 01-09 Ocular Manifestations of Systemic Inflammatory Disease.m4a
- 01-10 Internal Organ Involvement.m4a
- 01-11 Laboratory Studies.m4a
- 01-12 Session 1 Key Points.m4a
- 01-13 Close to Session 1.m4a
- 02-01 Introduction to Session 2.m4a
- 02-02 Complement and Autoantibody Tests.m4a
- 02-03 Autoantibodies in Rheumatologic Disease.m4a
- 02-04 Session MCQ Item 35 A 73-year-old Woman is Evaluated for Osteoarthritis.m4a
- 02-05 Imaging Studies.m4a
- 02-06 Joint Aspiration.m4a
- 02-07 Principles of Therapeutics.m4a
- 02-08 NSAIDs.m4a
- 02-09 Session MCQ Item 37 A 49-year-old Woman is Evaluated for Worsening Joint Symptoms.m4a
- 02-10 Colchicine.m4a
- 02-11 Analgesics and Pain Pathway Modulators.m4a
- 02-12 Session 2 Key Points.m4a
- 02-13 Close to Session 2.m4a
- 03-01 Introduction to Session 3.m4a
- 03-02 Disease-Modifying Antirheumatic Drugs.m4a
- 03-03 Nonbiologic DMARDs.m4a
- 03-04 Session MCQ Item 40 A 21-year-old Woman is Evaluated for Worsening Rash and Arthritis.m4a
- 03-05 Biologic DMARDs.m4a
- 03-06 Other Biologic Disease-Modifying Antirheumatic Drugs.m4a
- 03-07 Session MCQ Item 42 A 32-year-old Woman is Evaluated for Dry Eyes and Dry Mouth.m4a
- 03-08 Urate-Lowering Therapy.m4a
- 03-09 Rheumatologic Medications and Pregnancy.m4a
- 03-10 Vaccination and Screening in Immunosupression.m4a
- 03-11 Session 3 Key Points.m4a
- 03-12 Close to Session 3.m4a
- 04-01 Introduction to Session 4.m4a
- 04-02 Nonpharmacologic Measures To Address Pain.m4a
- 04-03 Rheumatoid Arthritis.m4a
- 04-04 Diagnosis.m4a
- 04-05 Session MCQ Item 43 A 67-year-old Woman is Seen for Severe Rheumatoid Arthritis.m4a
- 04-06 Consequences of Persistent Inflammation.m4a
- 04-07 Laboratory and Imaging Studies.m4a
- 04-08 Complications and Extra-Articular Manifestations.m4a
- 04-09 Session MCQ Item 54 A 30-year-old Woman is Evaluated for Pain and Swelling of the PIP Joints.m4a
- 04-10 Management.m4a
- 04-11 Disease-Modifying Antirheumatic Drugs.m4a
- 04-12 Session 4 Key Points.m4a
- 04-13 Close to Session 4.m4a
- 05-01 Introduction to Session 5.m4a
- 05-02 Pathophysiology of Osteoarthritis.m4a
- 05-03 Classification.m4a
- 05-04 Session MCQ Item 64 A 55-year-old Man is Evaluated for Progressive Joint Pain.m4a
- 05-05 Diffuse Idiopathic Skeletal Hyperostosis.m4a
- 05-06 Diagnosis.m4a
- 05-07 Laboratory and Imaging Studies.m4a
- 05-08 Session MCQ Item 75 A 53-year-old Woman is Evaluated for Sensory Loss in the Hands.m4a
- 05-09 Management.m4a
- 05-10 Pharmacologic Therapy.m4a
- 05-11 Fybromyalgia.m4a
- 05-12 Management.m4a
- 05-13 Session 5 Key Points.m4a
- 05-14 Close to Session 5.m4a
- 06-01 Introduction to Session 6.m4a
- 06-02 Spondyloarthritis.m4a
- 06-03 Classification of Spondyloarthritis.m4a
- 06-04 Session MCQ Item 88 A 40-year-old Woman is Evaluated for Inflammatory Arthritis.m4a
- 06-05 Ankylosing Spondylitis and Psoriatic Arthritis.m4a
- 06-06 Inflammatory Bowel Disease-Related Arthritis.m4a
- 06-07 Diagnosis.m4a
- 06-08 Session MCQ Item 95 A 48-year-old Man is Evaluated for Gout.m4a
- 06-09 Management.m4a
- 06-10 Session 6 Key Points.m4a
- 06-11 Close to Session 6.m4a
- 07-01 Introduction to Session 7.m4a
- 07-02 Systemic Lupus Erythematosis.m4a
- 07-03 Clinical Manifestations.m4a
- 07-04 Kidney Involvement.m4a
- 07-05 Cardiovascular and Pulmonary Involvement.m4a
- 07-06 Hematologic and Gastrointestinal Involvement.m4a
- 07-07 Association with Malignancy.m4a
- 07-08 Diagnosis.m4a
- 07-09 Laboratory Studies.m4a
- 07-10 Differential Diagnosis.m4a
- 07-11 Management.m4a
- 07-12 Session 7 Key Points.m4a
- 07-13 Close to Session 7.m4a
- 08-01 Introduction to Session 8.m4a
- 08-02 Pregnancy and Childbirth Issues.m4a
- 08-03 Sjogren Syndrome.m4a
- 08-04 Diagnosis of Sjogrens Syndrome.m4a
- 08-05 Management.m4a
- 08-06 Inflammatory Myopathies.m4a
- 08-07 Epidemiology and Pathophysiology of Inflammatory Myopathies.m4a
- 08-08 Polymyositis.m4a
- 08-09 Dermatomyositis.m4a
- 08-10 Inflammatory Myopathies and Malignancy.m4a
- 08-11 Diagnosis.m4a
- 08-12 Session 8 Key Points.m4a
- 08-13 Close to Session 8.m4a
- 09-01 Introduction to Session 9.m4a
- 09-02 Imaging.m4a
- 09-03 Management and Prognosis.m4a
- 09-04 Systemic Sclerosis.m4a
- 09-05 Common Features of the Scleroderma Spectrum Disorders.m4a
- 09-06 Clinical Manifestations and Diagnosis.m4a
- 09-07 Cutaneous Involvement.m4a
- 09-08 Musculoskeletal Involvement.m4a
- 09-09 Vascular Involvement.m4a
- 09-10 Kidney and Lung Involvement.m4a
- 09-11 Session 9 Key Points.m4a
- 09-12 Close to Session 9.m4a
- 10-01 Introduction to Session 10.m4a
- 10-02 Management.m4a
- 10-03 ACE Inhibitors.m4a
- 10-04 Mixed Connective Tissue Disease.m4a
- 10-05 Comparison of MCTD, UCT and Overlap Syndromes.m4a
- 10-06 Clinical Manifestations and Diagnosis.m4a
- 10-07 Crystal Arthropathies.m4a
- 10-08 Epidemiology and Pathophysiology of Gout.m4a
- 10-09 Causes of Hyperuricemia.m4a
- 10-10 Acute Gouty Arthritis.m4a
- 10-11 Intercritical Gout.m4a
- 10-12 Chronic Recurrent and Tophaceous Gout.m4a
- 10-13 Diagnosis.m4a
- 10-14 Pseudogout.m4a
- 10-15 Session 10 Key Points.m4a
- 10-16 Close to Session 10.m4a
- 11-01 Introduction to Session 11.m4a
- 11-02 Management of Gout.m4a
- 11-03 Urate-Lowering Therapy.m4a
- 11-04 Calcium Pyrophosphate Deposition.m4a
- 11-05 Clinical Manifestations and Diagnosis.m4a
- 11-06 Management.m4a
- 11-07 Infectious Arthritis.m4a
- 11-08 Laboratory and Imaging Studies.m4a
- 11-09 Infection with Gram-Positive Organisms.m4a
- 11-10 Disseminated Gonococcal Infection.m4a
- 11-11 Session 11 Key Points.m4a
- 11-12 Close to Session 11.m4a
- 12-01 Introduction to Session 12.m4a
- 12-02 Mycobacterium Tuberculosis.m4a
- 12-03 Viral Infections.m4a
- 12-04 Parvovirus B19.m4a
- 12-05 Prosthetic Joint Infections.m4a
- 12-06 Management.m4a
- 12-07 Systemic Vasculitis.m4a
- 12-08 Giant Cell Arteritis.m4a
- 12-09 Management.m4a
- 12-10 Polymyalgia Rheumatica.m4a
- 12-11 Takayasu Arteritis.m4a
- 12-12 Session 12 Key Points.m4a
- 12-13 Close to Session 12.m4a
- 13-01 Introduction to Session 13.m4a
- 13-02 Polyarteritis Nodosa.m4a
- 13-03 Primary Angiitis of the Central Nervous System.m4a
- 13-04 Kawasaki Disease.m4a
- 13-05 ANCA-Associated Vasculitis.m4a
- 13-06 Clinical Features of ANCA-Associated Vasculitis Disease.m4a
- 13-07 Granulomatosis with Polyangiitis.m4a
- 13-08 Microscopic Polyangiitis.m4a
- 13-09 Eosiophilic Granulomatosis with Polyangiitis.m4a
- 13-10 Immune Complex-Mediated Vasculitis.m4a
- 13-11 Cryoglobulinemic Vasculitis.m4a
- 13-12 IgA Vasculitis and Hypersensitivity Vasculitis.m4a
- 13-13 Session 13 Key Points.m4a
- 13-14 Close to Session 13.m4a
- 14-01 Introduction to Session 14.m4a
- 14-02 Other Rheumatologic Diseases.m4a
- 14-03 Relapsing Polychondritis.m4a
- 14-04 Adult-Onset Still Disease.m4a
- 14-05 Autoinflammatory Disease.m4a
- 14-06 Sarcoidosis.m4a
- 14-07 Genetic Diseases of Connective Tissue.m4a
- 14-08 IgG4-Related Disease.m4a
- 14-09 Session 14 Key Points.m4a
- 14-10 Close to Rheumatology Section.m4a